| Website | 5amventures.com |
| Phone | 650-233-8600 |
| Employees | |
| Founded | 2002 |
| Description | Venture capital Firm |
5AM Ventures is a seed and early-stage venture capital firm focused on building next-generation life science companies. Founded in 2002, 5AM Ventures has over $200 million under management and is actively investing its second fund. The firm has offices in Menlo Park, CA and Waltham, MA.
| Company | Date | Round | Size | Participants |
| pulmatrix | 11/09 | Series B | $30.2M | 4 |
| Flexion Therapeutics | 10/09 | Series A | $33M | 3 |
| Rennovia | 9/09 | Series A | $12.3M | 2 |
| Anaphore | 6/09 | Series A | $13M | 5 |
| Ambrx | 4/09 | Series D | $10M | 7 |
| pulmatrix | 3/09 | Series A | $3.5M | 2 |
| Synosia Therapeutics | 1/09 | Series B | $29M | 7 |
| KaloBios Pharmaceuticals | 12/08 | Series D | $12M | 8 |
| Semprus BioSciences | 12/08 | Series A | $8M | 2 |
| S*Bio | 10/08 | Unattributed | $26M | 6 |
| Pearl Therapeutics | 7/08 | Series A | $18M | 4 |
| Anaphore | 4/08 | Unattributed | $8M | 2 |
| Anaphore | 1/08 | Unattributed | $3.3M | 1 |
| Relypsa | 10/07 | Series A | $33M | 6 |
| Synosia Therapeutics | 1/07 | Unattributed | $32.5M | 4 |